Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Opexa Therapeutics, Inc.
Opexa Therapeutics Announces the Pricing of Public Offering of Shares of Common Stock and Series E Warrants
March 1st, 2008
Opexa Therapeutics, Inc. (NASDAQ:OPXA) announced that it has priced a public offering of 3,500,000 shares of common stock at a price to the public of $2.00 per share and 3,500,000 Series E warrants to purchase shares of common stock exercisable at $2.00 per share at a price of $0.15 per warrant. The Company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments. The Company expects to receive approximately $7.5 million (approximately $8.7 million if the underwriter's over-allotment option is exercised in full) in gross proceeds from the offering, which is subject to closing conditions. MDB Capital...
Source: Law & Health Weekly (2008-03-01)
|
